BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Policy

  Bradmer Pharmaceuticals Inc. Granted Orphan Drug Designation For Neuradiab In The Treatment Of Glioblastoma Multiforme By European Medicines Agency

  November 3, 2006

   · 

  1 min read
• Business

  BioLife Solutions And Corning Incorporated Announce Increased Cell Performance Through Product Combination

  November 3, 2006

   · 

  1 min read
• FDA

  NovaDel Pharma Receives FDA Approval Of NitroMist(TM)

  November 3, 2006

   · 

  5 min read
• Policy

  Neurocrine Biosciences, Inc. Delays Indiplon Application To Summer 2008

  November 3, 2006

   · 

  1 min read
• Business

  AnorMED Reports Fiscal 2007 Second Quarter Results And An Update On Recent Corporate Events

  November 3, 2006

   · 

  18 min read
• Business

  Neurogen Announces Third Quarter 2006 Financial Results

  November 3, 2006

   · 

  7 min read
• Lone Star Bio

  Nanospectra Raises $1.7M Series A Funding

  November 3, 2006

   · 

  1 min read
• Business

  Momenta Pharmaceuticals, Inc. Reports Financial Results For The Third Quarter Of 2006

  November 3, 2006

   · 

  7 min read
• Policy

  Encysive Pharmaceuticals Submits Complete Response To FDA For Thelin New Drug Application

  November 3, 2006

   · 

  1 min read
• Drug Development

  Next Clinical Trial Of VaxGen’s Anthrax Vaccine Delayed

  November 3, 2006

   · 

  2 min read